Overview


According to FutureWise analysis the market for Pharmaceutical Caps And Closure in 2023 is US$ 2.5 billion, and is expected to reach US$ 3.99 billion by 2031 at a CAGR of 6.00%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Caps And Closure Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Pharmaceutical Caps And Closure Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Berry Global Inc
  • Amcor Plc
  • Aptar, Inc.
  • Closure Systems International, Inc.
  • O.Berk Company, LLC
  • Bericap GmbH and Co KG
  • UNITED CAPS
  • CL Smith Company
  • Georg Menshen GmbhCo. Kg
  • WestRock Company
  • West Pharmaceutical Services, Inc
  • Drug Plastics & Glass Co Inc.
  • Gerresheimer AG
  • DWK Life Sciences GmbH
  • Parekhplast India Limited
  • Parshva Exim Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Screw Caps & Closure
  • Snap Caps & Closure
  • Push-Pull Caps & Closure
  • Stopper & Seals
  • Others

By Functionality

  • Child Resistant
  • Tamper-evident

By Material type

  • Plastics
    • Polypropylene
    • High Density Poly Ethylene (HDPE)
    • Low-density polyethylene (LDPE)
    • Cyclic Olefin Copolymer (COC)
    • Others
  • Elastomer
    • Synthetic Elastomer (Petroleum)
    • Natural Elastomer (Rubber)
  • Metal
    • Aluminium
    • Tinplate steel

By Availability

  • Prescription (Rx) Pharmaceuticals
  • "Over-the-Counter (OTC) Pharmaceuticals"

By Drug Modality

  • Small Molecule (Synthetic Drugs)
  • Biopharmaceuticals
    •  Recombinant Peptides & Proteins
    •  Monoclonal Antibodies (mAb)
    •  Vaccines
    •  Gene Therapeutics
    •  Cell & Gene Therapy (CGT)
    •  Antibody-drug Conjugate (ADC)

By Therapeutic class

  • Anticancer Drugs
  • Anti-infective Drugs
    •  Anti-viral Drugs
    •  Anti-bacterial Drugs
    •  Anti-fungal Drugs
    •  Others
  • Cardiovascular Drugs
  • Anti-inflammatory Drugs
  • Analgesics Drugs
  • Anti-diabetics
  • Ophthalmic Drugs
  • Neurological Drugs
  • Others

By End Users

  • Pharmaceutical & Biotechnology Companies
  • Contract Manufacturing  Organizations (CMO)
  • Contract Research Organizations (CRO)
  • Academic & Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Pharmaceutical Caps And Closure Market By Product Type, By Functionality, By Material type, By Availability, By Drug Modality, By Therapeutic class, By End Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Pharmaceutical Caps And Closure Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pharmaceutical Caps And Closure Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Pharmaceutical Caps And Closure Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Pharmaceutical Caps And Closure Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •  1. Screw Caps & Closure
        2. Snap Caps & Closure
        3. Push-Pull Caps & Closure
        4. Stopper & Seals
        5. Others

  • 8.   Global Pharmaceutical Caps And Closure Market, By Functionality Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Child Resistant
        2. Tamper-evident

  • 9.   Global Pharmaceutical Caps And Closure Market, By Material type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Plastics
         1.1. Polypropylene
         1.2. High Density Poly Ethylene (HDPE)
         1.3. Low-density polyethylene (LDPE)
         1.4. Cyclic Olefin Copolymer (COC)
         1.5. Others
        2. Elastomer
         2.1. Synthetic Elastomer (Petroleum)
         2.2. Natural Elastomer (Rubber)
        3. Metal
         3.1. Aluminium
         3.2. Tinplate steel

  • 10.   Global Pharmaceutical Caps And Closure Market, By Avalability Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prescription (Rx) Pharmaceuticals
        2. "Over-the-Counter (OTC) Pharmaceuticals"

  • 11.   Global Pharmaceutical Caps And Closure Market, By Drug Modality Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Small Molecule (Synthetic Drugs)
        2. Biopharmaceuticals
         2.1. Recombinant Peptides & Proteins
         2.2. Monoclonal Antibodies (mAb)
         2.3. Vaccines
         2.4. Gene Therapeutics
         2.5. Cell & Gene Therapy (CGT)
         2.6. Antibody-drug Conjugate (ADC)

  • 12.   Global Pharmaceutical Caps And Closure Market, By Therapeutic class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Anticancer Drugs
        2. Anti-infective Drugs
         2.1. Anti-viral Drugs
         2.2. Anti-bacterial Drugs
         2.3. Anti-fungal Drugs
         2.4. Others
        3. Cardiovascular Drugs
        4. Anti-inflammatory Drugs
        5. Analgesics Drugs
        6. Anti-diabetics
        7. Ophthalmic Drugs
        8. Neurological Drugs
        9. Others

  • 13.   Global Pharmaceutical Caps And Closure Market, By End Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical & Biotechnology Companies
        2. Contract Manufacturing Organizations (CMO)
        3. Contract Research Organizations (CRO)
        4. Academic & Research Institutes

  • 14.   North America Pharmaceutical Caps And Closure Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 15.   Latin America Pharmaceutical Caps And Closure Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 16.   Europe Pharmaceutical Caps And Closure Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 17.   Asia Pacific Pharmaceutical Caps And Closure Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 18.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 19.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 20.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •  1. Berry Global Inc
               1.1. Company Overview
               1.2. Product Portfolio
               1.3. SWOT Analysis
               1.4. Financial Overview
               1.5. Strategic Overview
         2. Amcor Plc
               2.1. Company Overview
               2.2. Product Portfolio
               2.3. SWOT Analysis
               2.4. Financial Overview
               2.5. Strategic Overview
         3. Aptar, Inc.
               3.1. Company Overview
               3.2. Product Portfolio
               3.3. SWOT Analysis
               3.4. Financial Overview
               3.5. Strategic Overview
         4. Closure Systems International, Inc.
               4.1. Company Overview
               4.2. Product Portfolio
               4.3. SWOT Analysis
               4.4. Financial Overview
               4.5. Strategic Overview
         5. O.Berk Company, LLC
               5.1. Company Overview
               5.2. Product Portfolio
               5.3. SWOT Analysis
               5.4. Financial Overview
               5.5. Strategic Overview          
         6. Bericap GmbH and Co KG
               6.1. Company Overview
               6.2. Product Portfolio
               6.3. SWOT Analysis
               6.4. Financial Overview
               6.5. Strategic Overview      
         7. UNITED CAPS
               7.1. Company Overview
               7.2. Product Portfolio
               7.3. SWOT Analysis
               7.4. Financial Overview
               7.5. Strategic Overview
         8. CL Smith Company
               8.1. Company Overview
               8.2. Product Portfolio
               8.3. SWOT Analysis
               8.4. Financial Overview
               8.5. Strategic Overview
         9. Georg Menshen Gmbh & Co. Kg
               9.1. Company Overview
               9.2. Product Portfolio
               9.3. SWOT Analysis
               9.4. Financial Overview
               9.5. Strategic Overview
         10.WestRock Company
               10.1. Company Overview
               10.2. Product Portfolio
               10.3. SWOT Analysis
               10.4. Financial Overview
               10.5. Strategic Overview
         11.West Pharmaceutical Services, Inc
               11.1. Company Overview
               11.2. Product Portfolio
               11.3. SWOT Analysis
               11.4. Financial Overview
               11.5. Strategic Overview
         12.Drug Plastics & Glass Co Inc.
               12.1. Company Overview
               12.2. Product Portfolio
               12.3. SWOT Analysis
               12.4. Financial Overview
               12.5. Strategic Overview
         13.Gerresheimer AG
               13.1. Company Overview
               13.2. Product Portfolio
               13.3. SWOT Analysis
               13.4. Financial Overview
               13.5. Strategic Overview
         14.DWK Life Sciences GmbH
               14.1. Company Overview
               14.2. Product Portfolio
               14.3. SWOT Analysis
               14.4. Financial Overview
               14.5. Strategic Overview
         15.Parekhplast India Limited
               15.1. Company Overview
               15.2. Product Portfolio
               15.3. SWOT Analysis
               15.4. Financial Overview
               15.5. Strategic Overview          
         16.Parshva Exim Limited
               16.1. Company Overview
               16.2. Product Portfolio
               16.3. SWOT Analysis
               16.4. Financial Overview
               16.5. Strategic Overview

  • 21.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 22.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients